Status:
COMPLETED
Central Obesity in Cases of OAB
Lead Sponsor:
Mansoura University
Conditions:
Urologic Diseases
Overactive Bladder Syndrome
Eligibility:
All Genders
18-40 years
Phase:
NA
Brief Summary
Obesity is not a homogeneous condition and that the regional distribution of adipose tissue is important to understanding the relation of obesity to disturbances in glucose and lipid metabolism. Centr...
Detailed Description
Overactive bladder (OAB) is defined by international continence society (ICS) as urinary urgency with or without incontinence often associated with frequency and nocturia. As a chronic, unbearable con...
Eligibility Criteria
Inclusion
- patients with OAB between 18 and 40 years old.
- normal variant healthy donor as a control.
Exclusion
- Patients who have any of the following:
- Age less than 18 or more than 40 years old
- Neurogenic detrusor overactivity
- evidence of obstructed flow in absence of prolapse
- mixed urinary incontinence
- associated urethral pathology, e.g. Urethral diverticulum
- Associated bladder pathology e.g. fistula, active urinary tract infection as evidenced by positive urine culture
- previous exposure for anticholinergics or BTX-A injection.
Key Trial Info
Start Date :
January 1 2017
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 30 2018
Estimated Enrollment :
250 Patients enrolled
Trial Details
Trial ID
NCT03750604
Start Date
January 1 2017
End Date
October 30 2018
Last Update
November 23 2018
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.